986 related articles for article (PubMed ID: 33429932)
1. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
2. The MeCP2E1/E2-BDNF-
Pejhan S; Del Bigio MR; Rastegar M
Front Cell Dev Biol; 2020; 8():763. PubMed ID: 32974336
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Regulation of
Buist M; Fuss D; Rastegar M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439919
[TBL] [Abstract][Full Text] [Related]
4. Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to
Buist M; El Tobgy N; Shevkoplyas D; Genung M; Sher AA; Pejhan S; Rastegar M
Cells; 2022 Apr; 11(9):. PubMed ID: 35563748
[TBL] [Abstract][Full Text] [Related]
5. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
[TBL] [Abstract][Full Text] [Related]
6. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
9. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
10. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
11. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
[TBL] [Abstract][Full Text] [Related]
12. Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes.
Zachariah RM; Olson CO; Ezeonwuka C; Rastegar M
PLoS One; 2012; 7(11):e49763. PubMed ID: 23185431
[TBL] [Abstract][Full Text] [Related]
13. TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome.
Steinkellner H; Kempaiah P; Beribisky AV; Pferschy S; Etzler J; Huber A; Sarne V; Neuhaus W; Kuttke M; Bauer J; Arunachalam JP; Christodoulou J; Dressel R; Mildner A; Prinz M; Laccone F
Int J Biol Macromol; 2022 Jun; 209(Pt A):972-983. PubMed ID: 35460749
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs.
Leoncini S; De Felice C; Signorini C; Zollo G; Cortelazzo A; Durand T; Galano JM; Guerranti R; Rossi M; Ciccoli L; Hayek J
Oxid Med Cell Longev; 2015; 2015():421624. PubMed ID: 26236424
[TBL] [Abstract][Full Text] [Related]
15. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
16.
Anitha A; Poovathinal SA; Viswambharan V; Thanseem I; Iype M; Anoop U; Sumitha PS; Parakkal R; Vasu MM
Neurol India; 2022; 70(1):249-253. PubMed ID: 35263890
[TBL] [Abstract][Full Text] [Related]
17. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
18. [Genetic features and mechanism of Rett syndrome in Chinese population].
Zhang X; Zhao Y; Bao X; Zhang J; Cao G; Wu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):1-5. PubMed ID: 24510551
[TBL] [Abstract][Full Text] [Related]
19. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
[TBL] [Abstract][Full Text] [Related]
20. Metformin Induces MeCP2 in the Hippocampus of Male Mice with Sex-Specific and Brain-Region-Dependent Molecular Impact.
Arezoumand KS; Roberts CT; Rastegar M
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
